Researchers at UT Southwestern Medical Center found that tenecteplase, a newer drug, is just as safe and effective as ...

A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug ...

My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...

Massachusetts residents are sick and tired of paying taxes, and a new poll shows strong opposition from likely voters on Gov. Maura Healey’s proposal to reinstitute a long-dormant fee on ...

Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

The measure, which passed with bipartisan support and minor changes, now heads back to the House. It is just the second ...

The Senate is preparing to give final approval to a bill that could result in harsher prison sentences for fentanyl ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...

After days of Democratic agonizing, the Senate voted to keep federal funds flowing through Sept. 30 just hours before a ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...